Search

everythinglearnresearchcommunity

for

Search:↓

Blood stasis is the main cause of spot baldness, and treatments should focus on improving blood circulation.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.

Dogs have a skin condition like human pseudopelade, causing hair loss that doesn't improve with treatment.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Recent discoveries have improved our understanding of hair loss, but challenges in treatment and knowledge among specialists still exist.

A 16-year-old boy's facial condition improved with doxycycline, suggesting an immune response to hair follicle damage.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.